source

Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering

December 11, 2025 18:25 ET  | Source: Surgery Partners, Inc. BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners,…

4 weeks ago

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

December 10, 2025 18:00 ET  | Source: Fortrea Holdings Inc DURHAM, N.C., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq:…

4 weeks ago

AMSC Accelerates the Business, Expands Product Portfolio, and Enters Brazil with Comtrafo Acquisition

December 10, 2025 16:06 ET  | Source: AMSC Transaction Expected to be Accretive to Revenue and Earnings Expands Product Offerings…

4 weeks ago

Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

December 09, 2025 21:50 ET  | Source: Wave Life Sciences USA, Inc. CAMBRIDGE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) --…

4 weeks ago

Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock

December 09, 2025 21:42 ET  | Source: Dyne Therapeutics, Inc. WALTHAM, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc.…

4 weeks ago

PodToBook AI Launches Innovative Platform to Convert Podcasts into Book Manuscripts

New AI Technology Transforms RSS Feeds Into Structured Book Chapters Without Writing A Word December 09, 2025 17:17 ET  |…

4 weeks ago

CPI Aerostructures Appoints Robert Mannix as Chief Financial Officer

December 09, 2025 17:15 ET  | Source: CPI Aerostructures, Inc. EDGEWOOD, N.Y., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CPI Aerostructures,…

4 weeks ago

Latest Data of InnoCares Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)

December 08, 2025 21:04 ET  | Source: InnoCare Pharma BEIJING, Dec. 08, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969;…

4 weeks ago

TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

December 06, 2025 17:30 ET  | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…

1 month ago

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear dose-response observed, with a robust and clinically meaningful…

1 month ago